These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31107822)

  • 1. Changes of T-cell Immunity Over a Lifetime.
    Nian Y; Minami K; Maenesono R; Iske J; Yang J; Azuma H; ElKhal A; Tullius SG
    Transplantation; 2019 Nov; 103(11):2227-2233. PubMed ID: 31107822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different in vitro proliferation and cytokine-production inhibition of memory T-cell subsets after calcineurin and mammalian target of rapamycin inhibitors treatment.
    Merino D; San Segundo D; Medina JM; Rodrigo E; Asensio E; Irure J; Fernández-Fresnedo G; Arias MA; López-Hoyos M
    Immunology; 2016 Jun; 148(2):206-15. PubMed ID: 26931075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells.
    Avila CL; Zimmerer JM; Elzein SM; Pham TA; Abdel-Rasoul M; Bumgardner GL
    Transplantation; 2016 Sep; 100(9):1898-906. PubMed ID: 27362313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review on Role of Mammalian Target of Rapamycin Inhibitors as an Alternative to Calcineurin Inhibitors in Renal Transplant: Challenges and Window to Excel.
    Kumar J; Bridson JM; Sharma A; Halawa A
    Exp Clin Transplant; 2017 Jun; 15(3):241-252. PubMed ID: 27915965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effector Antitumor and Regulatory T Cell Responses Influence the Development of Nonmelanoma Skin Cancer in Kidney Transplant Patients.
    Crespo E; Fernandez L; Lúcia M; Melilli E; Lauzurica R; Penin RM; Quer A; Luque S; Quero M; Manonelles A; Torras J; Cruzado JM; Cañas L; Grinyó JM; Bestard O
    Transplantation; 2017 Sep; 101(9):2102-2110. PubMed ID: 28403126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation.
    Helal I; Chan L
    Transplant Proc; 2011 Mar; 43(2):472-7. PubMed ID: 21440737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells.
    Gallon L; Traitanon O; Yu Y; Shi B; Leventhal JR; Miller J; Mas V; L X; Mathew JM
    Transplantation; 2015 Sep; 99(9):1774-84. PubMed ID: 25905982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Renal Function in Liver Transplant Recipients After Conversion From Calcineurin Inhibitors to mTOR Inhibitors.
    Hüsing A; Schmidt M; Beckebaum S; Cicinnati VR; Koch R; Thölking G; Stella J; Heinzow H; Schmidt HH; Kabar I
    Ann Transplant; 2015 Nov; 20():707-13. PubMed ID: 26608590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses.
    Ye L; Lee J; Xu L; Mohammed AU; Li W; Hale JS; Tan WG; Wu T; Davis CW; Ahmed R; Araki K
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27974559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A color-coded reporter model to study the effect of immunosuppressants on CD8+ T-cell memory in antitumor and alloimmune responses.
    Rovira J; Sabet-Baktach M; Eggenhofer E; Lantow M; Koehl GE; Schlitt HJ; Campistol JM; Geissler EK; Kroemer A
    Transplantation; 2013 Jan; 95(1):54-62. PubMed ID: 23222894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An mTOR-inhibitor-based protocol and calcineurin inhibitor (CNI)-free treatment in kidney transplant recipients from donors after cardiac death: good renal function, but high incidence of conversion to CNI.
    Sánchez-Escuredo A; Diekmann F; Revuelta I; Esforzado N; Ricart MJ; Cofán F; Torregrosa JV; Peri L; Ruiz Á; Campistol JM; Oppenheimer F
    Transpl Int; 2016 Mar; 29(3):362-8. PubMed ID: 26678359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian Target of Rapamycin Inhibitors Combined With Calcineurin Inhibitors as Initial Immunosuppression in Renal Transplantation: A Meta-analysis.
    Montero N; Quero M; Melilli E; Pérez-Sáez MJ; Redondo-Pachón D; Bestard O; Crespo M; Cruzado JM; Pascual J
    Transplantation; 2019 Oct; 103(10):2031-2056. PubMed ID: 31343574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oscillatory mTOR inhibition and Treg increase in kidney transplantation.
    Sabbatini M; Ruggiero G; Palatucci AT; Rubino V; Federico S; Giovazzino A; Apicella L; Santopaolo M; Matarese G; Galgani M; Terrazzano G
    Clin Exp Immunol; 2015 Nov; 182(2):230-40. PubMed ID: 26077103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early use of renal-sparing agents in liver transplantation: a closer look.
    Trotter JF; Grafals M; Alsina AE
    Liver Transpl; 2013 Aug; 19(8):826-42. PubMed ID: 23696464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model.
    Reese SR; Wilson NA; Huang G; Redfield RR; Zhong W; Djamali A
    Transplantation; 2015 Sep; 99(9):1785-95. PubMed ID: 25919767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo alloreactive memory CD8+ T cells develop following allogeneic challenge when CNI immunosuppression is delayed.
    Hart-Matyas M; Gareau AJ; Hirsch GM; Lee TD
    Transpl Immunol; 2015 Jan; 32(1):23-8. PubMed ID: 25315500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B; Höcker B
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy.
    Helmschrott M; Rivinius R; Bruckner T; Katus HA; Doesch AO
    Drug Des Devel Ther; 2017; 11():1673-1680. PubMed ID: 28652705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Immune-Modulatory Drugs on Regulatory T Cell.
    Furukawa A; Wisel SA; Tang Q
    Transplantation; 2016 Nov; 100(11):2288-2300. PubMed ID: 27490409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cells.
    De Bruyne R; Bogaert D; De Ruyck N; Lambrecht BN; Van Winckel M; Gevaert P; Dullaers M
    Clin Exp Immunol; 2015 Jun; 180(3):542-50. PubMed ID: 25682989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.